The Patient Was Eligible. Nobody Told Them.
Clinical trials are actively recruiting the populations that community health centers serve. Most health centers have no system for connecting.
A systematic review found 33 clinical trials involving 67 FQHCs across the entire United States. Most of that engagement was passive, informed or consulted, not collaborative. The populations trials most need to reach are sitting in the panels of the organizations least connected to the trial communication network.
The trial is open. The eligibility criteria match your patient population. Your providers don't know it exists. Your patients definitely don't.
That is not an unusual situation for a community health center. Clinical trial awareness moves through academic medical centers, specialty practices, and research infrastructure that most FQHCs are not part of. The communication gap is not a side effect of how trials operate; it is built into how they are designed and announced. The result is a predictable mismatch: trials recruiting the populations community health centers serve, and community health centers sitting outside the system that would connect them.
Changing this does not require becoming a clinical trial site, though some FQHCs already are and more could be. It requires building four specific capabilities that most health centers are not running intentionally: clinical staff awareness, patient-facing communication, navigation support, and community positioning. None of these are new capabilities. They are applications of what health centers already do, pointed at a problem the current trial enrollment architecture is making worse every cycle.
Build Trial Awareness Into the Clinical Workflow
The first gap is the most basic: most FQHC clinical staff lack a reliable way to know which trials are currently open for their patient population. Trial information is available; the NCI's trial finder is current, and disease-specific advocacy organizations publish plain-language enrollment summaries, but that information has no clear path into the clinical workflow of a primary care practice operating under significant administrative load.
The fix is procedural, not technological. Designate one clinical staff member, a care coordinator, a senior MA or a nurse manager, to check the NCI's trial finder monthly for the health center's most common chronic conditions and cancer diagnoses. Summarize what's open, what the basic eligibility criteria are, and whether the trial site requires travel. Distribute that summary at the monthly clinical team meeting. If nothing relevant is open, say so. If something is, the providers who might have an eligible patient now know to ask.
This is not a research program. It is a communication practice. The organizations that have built it report that awareness alone changes the clinical conversation; providers who know a trial is open start identifying candidates they would previously have had no reason to mention it to. The awareness has to exist before anything else can follow.
The trial information exists. The problem is that it has no clear path into the clinical workflow of a primary care practice already running at capacity. Fixing that is a procedural decision, not a technology investment.
Make the Eligibility Conversation Routine
The second capability is patient-facing: building clinical trial eligibility into the conversations that already happen at the point of care.
For patients with cancer diagnoses, this matters most and most urgently. Research analyzing SEER-Medicaid linked data found that patients who enrolled in Medicaid after a cancer diagnosis, meaning they came into coverage through the crisis of a diagnosis, faced odds of late-stage disease 3.41 times higher for breast cancer, 3.78 times higher for colorectal, and 1.87 times higher for lung cancer compared to patients enrolled before diagnosis. Late-stage presentation is not just a prognosis problem. It is a trial eligibility problem. Many trials require earlier-stage disease. The patients who most need access to emerging treatment options are often already past the enrollment window by the time someone thinks to ask.
This means the eligibility conversation needs to happen earlier than feels natural, at initial chronic disease diagnosis, at the first cancer follow-up, before the disease trajectory has narrowed the options. For health centers serving high proportions of Medicaid-enrolled patients, this urgency is compounded: the population most likely to benefit from trial access is also the one most likely to present late.
The provider's role in this conversation is not to explain the trial in detail. It is to surface the option: "There may be a study enrolling patients with your diagnosis. I'd like to have someone follow up with you about whether you qualify." That handoff, made consistently, creates the pipeline; everything after it is navigation work.
Extend Navigation to Trial Participation
Community health centers run patient navigation programs. Transportation assistance, consent form translation, help understanding insurance implications, appointment accompaniment — these are services health centers already provide for patients navigating complex care pathways. Clinical trial participation is a complex care pathway. The barriers are the same ones navigation programs are built to address.
The extension is straightforward: when a provider identifies a potentially eligible patient, navigation support becomes available for the trial participation process. Travel to the trial site. Time off from work for study visits. Consent documentation in the patient's language. Clarity on how trial participation interacts with existing Medicaid coverage. These are not exotic barriers. They are the same barriers that prevent health center patients from completing referrals, attending specialist appointments, and following up on abnormal test results. Navigation programs that address those barriers can address these.
What is required is a procedural handoff: an agreement between the provider who identifies the candidate and the navigator who will follow up, a workflow to track whether the patient connected with the trial site, and someone accountable for closing the loop. This does not require a grant or a new program. It requires adding clinical trial navigation to the existing navigator's scope of work and building the tracking to match.
Communicate It to the Community
The fourth move is external: telling the community that the health center is doing this work.
Most FQHCs do not communicate about clinical trial access at all. Trials feel like academic medicine, something that happens at university hospitals, not community health centers. That perception is part of what keeps the populations who most need trial access from knowing it is available to them. A health center that has built trial awareness, clinical eligibility conversations, and navigation support has something real to communicate. It is not a marketing exercise. It is information the community needs and doesn't currently have.
The communication is simple: we are connected to what is currently enrolling; if you have a diagnosis that might qualify you, ask your provider; we have navigation support for people who want to pursue it. That message, distributed through the health center's existing community channels, patient portal, waiting room materials and community health worker conversations, creates the demand that makes the internal process worth running.
It also positions the health center as something more than a primary care provider. The organization that actively connects patients to research opportunities is communicating something about what it believes its patients deserve: access to the emerging edge of what medicine knows, not just the options that find their way to them on their own. That is a differentiated position that matters in communities where healthcare institutions have long histories of excluding exactly this population from research participation.
The organizations that communicate this work publicly, to the community, to referring providers, to donors, are earning a differentiated position that the current trial communication architecture is making easy to claim. Most health centers aren't claiming it.
What This Looks Like in Practice
A health center that builds all four of these capabilities has created something the current clinical trial communication architecture does not provide: a functional connection between the populations trials most need and the institutions closest to those populations.
The monthly trial awareness check is a one-hour task for one staff member. The provider handoff language is a paragraph added to the clinical team's standard conversation framework. The navigator scope expansion is a workflow conversation and a tracking column in the existing navigation dashboard. Community communication consists of a paragraph on the website and a talking point for community health workers. None of these are large investments. Together, they constitute a program.
The organizations running this well are not the ones with research infrastructure or dedicated trial staff. They are the ones who have been deliberate about the problem: that their patients are eligible for trials they will never hear about, that the reason is structural rather than inevitable, and that the organization is positioned to interrupt it in ways that academic medical centers are not. The argument for doing it is partly clinical, partly ethical, and partly organizational: the health centers building the deepest patient relationships are the ones whose patients know, concretely, that the organization is looking out for them beyond the walls of the exam room.
Some ideas are worth discussing in the context of your organization.
